Clinical Trials Browser

Phase 3 × INDUSTRY × Neuroblastoma × Clear all

NCT04724369 2025-03-26

Open-Label Study of 18F-mFBG for Imaging Neuroblastoma

Phase 3 Completed

Neuroblastoma

NCT00126412 2019-05-31

Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma

Phase 3 Completed

Disease, Neuroblastoma, Pheochromocytoma